Saluda Medical shares plummet on Australian market debut – Reuters
- Saluda Medical shares plummet on Australian market debut Reuters
- Biocurious: Saluda Medical’s IPO tackles the $35-billion-a-year chronic pain market Stockhead
- Saluda Medical the latest Aussie-founded medtech set for an ASX debut after raising $231m Business News Australia
- Saluda to expand spinal cord stimulation market in AU$231M IPO BioWorld MedTech
- Johson Winter Slattery advises Saluda Medical, Inc. (ASX:SLD) on its IPO and ASX Listing Johnson Winter Slattery